19 Results for "

sclerostin

" in MedChemExpress (MCE) Product Catalog:
Products (19)

19 Results for "sclerostin" in MCE Product Catalog:

  • Isoforms Recommended:
1
1 Cited Publications
Cat. No.: HY-P9982
CAS No.: 909395-70-6
Synonyms: AMG-785; CDP-7851

Target:  

Inhibitory Antibodies

Research Areas:  

Endocrinology Cancer

Romosozumab is a humanized monoclonal anti-sclerostin antibody, it promotes bone formation and inhibits bone resorption by inhibiting sclerostin. Romosozumab can be used for the research of osteoporosis .
loading...
    loading...
Cat. No.: HY-P99186
CAS No.: 1132758-87-2

Target:  

Inhibitory Antibodies

Research Areas:  

Others

Blosozumab (LY2541546) is an anti-Human sclerostin (SOST) antibody inhibitor. Blosozumab stimulates bone formation and reduces bone resorption. Blosozumab can be used in the research of Osteoporosis .
loading...
    loading...
Cat. No.: HY-170788
CAS No.: 3074559-75-1
Research Areas:  

Metabolic Disease

PDE7A-IN-1 is an orally active and selective PDE7A inhibitor with an IC50 of 0.0037 μM against PDE7A. PDE7A-IN-1 shows excellent isozyme selectivity over PDE7B. PDE7A-IN-1 elevates intracellular cAMP levels, suppresses ECR5 enhancer activity and reduces sclerostin expression. PDE7A-IN-1 significantly increases bone mineral density in rats. PDE7A-IN-1 can be used for the study of osteoporosis .
loading...
    loading...
Cat. No.: HY-P99398
CAS No.: 1847394-95-9
Synonyms: BPS 804

Target:  

Inhibitory Antibodies

Research Areas:  

Inflammation/Immunology Cancer

Setrusumab (BPS 804) is a fully human monoclonal antibody targets sclerostin. Setrusumab efftively improves bone strength. Setrusumab can be used for the resesrch of Osteogenesis Imperfecta (OI) and cancer .
loading...
    loading...
Cat. No.: HY-125146
CAS No.: 301357-87-9
Purity:  99.21%
Target:  

Wnt

Research Areas:  

Others

BMD4503-2 is a quinoxaline derivative with inhibitory activity against LRP5/6-sclerostin interactions. BMD4503-2 restores the activity of the Wnt/β-catenin signaling pathway by competitively binding to the LRP5/6-sclerostin complex. BMD4503-2 can be used in the study of Wnt signaling pathways in bone development, maintenance and osteoporosis .
loading...
    loading...
Cat. No.: HY-163513
CAS No.: 2515609-54-6
Target:  

Wnt

Research Areas:  

Endocrinology

AACA is an inhibitor for sclerostin, that binds sclerostin on loop3 region with Kd of 15.4 nM. AACA exhibits anti-osteoporosis activity through Wnt signaling pathway .
loading...
    loading...
Cat. No.: HY-169508
CAS No.: 301357-76-6
Target:  

Wnt

Research Areas:  

Others

BMD4503-1 is a quinoxaline derivative. BMD4503-1 can inhibit the LRP5/6-Sclerostin interaction and regulate the Wnt signaling pathway .
loading...
    loading...
Cat. No.: HY-P991617
CAS No.: 1798349-30-0

Target:  

Wnt

Research Areas:  

Cancer

AMG-167 is an anti-cancer monoclonal antibody targeting sclerostin. AMG-167 can be studied in research for osteoporosis .
loading...
    loading...
Cat. No.: HY-P992113
CAS No.: 3061142-96-6
Synonyms: AGA2118
Target:  

Wnt β-catenin

Research Areas:  

Metabolic Disease

Evabosmig (AGA2118) is a humanized bispecific monoclonal antibody targeting sclerostin (SOST/sclerostin) and DKK1. SOST and DKK1 are two key secreted negative regulators of the intramedullary Wnt/β-catenin pathway. Evabosmig possesses activities to induce bone formation, inhibit bone resorption and increase bone mineral density. Evabosmig is applicable for research related to osteoporosis .
loading...
    loading...
Cat. No.: HY-P71623
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: SOST; Sclerosteosis; sclerostin; SOST1; DAND6; CDD; VBCH
Species:  
Rat
Source:  
E. coli
loading...
    loading...
Cat. No.: HY-P70717
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: SOST; Sclerosteosis; sclerostin; SOST1; DAND6; CDD; VBCH
Species:  
Mouse
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-P70756
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: SOST; Sclerosteosis; sclerostin; SOST1; DAND6; CDD; VBCH
Species:  
Human
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-P700829
Purity:  ≥ 95%, as determined by reducing Bis-Tris PAGE.
Synonyms: SOST; Sclerosteosis; sclerostin; SOST1; DAND6; CDD; VBCH
Species:  
Cynomolgus
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-P78209
Purity:  ≥ 95%, as determined by Bis-Tris PAGE.
Synonyms: SOST; Sclerosteosis; sclerostin; SOST1; DAND6; CDD; VBCH
Species:  
Human
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-185590
CAS No.: 3084453-02-8
Research Areas:  

Cancer

tri-GalNAc-phosphoric acid is a specific ligand of ASGPR with cell-specific internalization capability. tri-GalNAc-phosphoric acid can mediate the delivery of conjugated sclerostin aptamers to lysosomes of cells expressing ASGPR. tri-GalNAc-phosphoric acid is applicable to anticancer research .
loading...
    loading...
Cat. No.: HY-P811321
Synonyms: sclerostin, Sost

Host:  

Rabbit

Application:  

WB, IHC-P

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
Cat. No.: HY-P79350
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: sclerostin domain-containing protein 1; Ectodermal BMP inhibitor; Ectodin; sclerostin-like protein; Uterine sensitization-associated gene 1 protein; USAG-1
Species:  
Mouse
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-P78804
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: SOST; Sclerosteosis; sclerostin; SOST1; DAND6; CDD; VBCH
Species:  
Human
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-P78765
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: SOSTDC1; Ectodermal BMP Inhibitor; sclerostin Domain Containing 1; DKFZp564D206; USAG1; Wise; sclerostin Domain-Containing Protein 1; Uterine Sensitization-Associated Protein-1; Ectodin; Cystine-Knot Containing Secreted Protein; DAND7; CDA019; Uterine Sen
Species:  
Human
Source:  
HEK293
loading...
    loading...
  • 1